Adverse Event Profile in Advance Hepatocellular Carcinoma treated with Sorafenib Presenting to CMH Rawalpindi
Objective: To look for adverse event profiles in advance of hepatocellular carcinoma treated with Sorafenib presenting to CMH Rawalpindi and study associated socio-demographic factors Study Design: Comparative cross-sectional study Place and Duration of Study: Oncology Department, Combin...
Main Authors: | Masaba Masood, Muhammad Nadeem, Aamira Ali, Tahir Manzoor Lone, Amjad Khan, Assam Ahmad |
---|---|
Format: | Article |
Language: | English |
Published: |
Army Medical College Rawalpindi
2023-08-01
|
Series: | Pakistan Armed Forces Medical Journal |
Subjects: | |
Online Access: | https://www.pafmj.org/index.php/PAFMJ/article/view/7889 |
Similar Items
-
Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma
by: Anna Soria, et al.
Published: (2022-08-01) -
Sorafenib for Egyptian patients with advanced hepatocellular carcinoma; single center experience
by: Omar Abdel-Rahman, et al.
Published: (2014-03-01) -
Sorafenib in the treatment of advanced hepatocellular carcinoma
by: Mousa Ali
Published: (2008-01-01) -
Jianpi Huayu Decoction enhances the effect of sorafenib and alleviates adverse events in hepatocellular carcinoma by remodeling the gut microbiota
by: Xue Deng, et al.
Published: (2022-03-01) -
Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular Carcinoma
by: Josep Corominas, et al.
Published: (2021-01-01)